183 related articles for article (PubMed ID: 15352032)
1. Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts.
San Francisco IF; DeWolf WC; Peehl DM; Olumi AF
Int J Cancer; 2004 Nov; 112(2):213-8. PubMed ID: 15352032
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
3. Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma.
Costea DE; Hills A; Osman AH; Thurlow J; Kalna G; Huang X; Pena Murillo C; Parajuli H; Suliman S; Kulasekara KK; Johannessen AC; Partridge M
Cancer Res; 2013 Jul; 73(13):3888-901. PubMed ID: 23598279
[TBL] [Abstract][Full Text] [Related]
4. Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a population study.
Casey TM; Eneman J; Crocker A; White J; Tessitore J; Stanley M; Harlow S; Bunn JY; Weaver D; Muss H; Plaut K
Breast Cancer Res Treat; 2008 Jul; 110(1):39-49. PubMed ID: 17674196
[TBL] [Abstract][Full Text] [Related]
5. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
[TBL] [Abstract][Full Text] [Related]
6. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.
Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M
Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464
[TBL] [Abstract][Full Text] [Related]
9. Growth factor regulation of secreted matrix metalloproteinase and plasminogen activators in prostate cancer cells, normal prostate fibroblasts and normal osteoblasts.
Forbes K; Webb MA; Sehgal I
Prostate Cancer Prostatic Dis; 2003; 6(2):148-53. PubMed ID: 12806374
[TBL] [Abstract][Full Text] [Related]
10. Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression.
Tu H; Jacobs SC; Borkowski A; Kyprianou N
Int J Cancer; 1996 Oct; 69(5):357-63. PubMed ID: 8900367
[TBL] [Abstract][Full Text] [Related]
11. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
Festuccia C; Angelucci A; Gravina GL; Villanova I; Teti A; Albini A; Bologna M
Int J Cancer; 2000 Feb; 85(3):407-15. PubMed ID: 10652434
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
13. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
14. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
Cipriano SC; Chen YQ
Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
[TBL] [Abstract][Full Text] [Related]
15. Survivin expression is associated with features of biologically aggressive prostate carcinoma.
Shariat SF; Lotan Y; Saboorian H; Khoddami SM; Roehrborn CG; Slawin KM; Ashfaq R
Cancer; 2004 Feb; 100(4):751-7. PubMed ID: 14770431
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation.
Cotrim P; de Andrade CR; Martelli-Junior H; Graner E; Sauk JJ; Coletta RD
J Periodontol; 2002 Nov; 73(11):1313-22. PubMed ID: 12479636
[TBL] [Abstract][Full Text] [Related]
17. A novel human cancer culture model for the study of prostate cancer.
Yasunaga Y; Nakamura K; Ko D; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Rhim JS
Oncogene; 2001 Nov; 20(55):8036-41. PubMed ID: 11753687
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts.
Rosenthal E; McCrory A; Talbert M; Young G; Murphy-Ullrich J; Gladson C
Mol Carcinog; 2004 Jun; 40(2):116-21. PubMed ID: 15170816
[TBL] [Abstract][Full Text] [Related]
19. Role of transforming growth factor-beta1 in prostate cancer.
Wikström P; Damber J; Bergh A
Microsc Res Tech; 2001 Feb; 52(4):411-9. PubMed ID: 11170300
[TBL] [Abstract][Full Text] [Related]
20. Negative control of epithelial cell proliferation by prostatic stroma.
Kooistra A; König JJ; Romijn JC; Schröder FH
Anticancer Res; 1991; 11(4):1495-500. PubMed ID: 1720936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
